185 related articles for article (PubMed ID: 15830147)
1. Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer.
Ferretti G; Mandalà M; Bria E; Carlini P; Papaldo P; Fabi A; Felici A; Cognetti F
Breast Cancer Res Treat; 2005 Apr; 90(3):319. PubMed ID: 15830147
[No Abstract] [Full Text] [Related]
2. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
Pötter R; Gnant M; Kwasny W; Tausch C; Handl-Zeller L; Pakisch B; Taucher S; Hammer J; Luschin-Ebengreuth G; Schmid M; Sedlmayer F; Stierer M; Reiner G; Kapp K; Hofbauer F; Rottenfusser A; Pöstlberger S; Haider K; Draxler W; Jakesz R;
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):334-40. PubMed ID: 17363187
[TBL] [Abstract][Full Text] [Related]
3. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.
Hughes KS; Schnaper LA; Berry D; Cirrincione C; McCormick B; Shank B; Wheeler J; Champion LA; Smith TJ; Smith BL; Shapiro C; Muss HB; Winer E; Hudis C; Wood W; Sugarbaker D; Henderson IC; Norton L; ; ;
N Engl J Med; 2004 Sep; 351(10):971-7. PubMed ID: 15342805
[TBL] [Abstract][Full Text] [Related]
4. Breast radiotherapy after lumpectomy--no longer always necessary.
Smith IE; Ross GM
N Engl J Med; 2004 Sep; 351(10):1021-3. PubMed ID: 15342811
[No Abstract] [Full Text] [Related]
5. Is radiation necessary for older women with breast cancer? Once the tumor is removed, tamoxifen by itself is effective, but for younger women it's a very different story.
Health News; 2004 Dec; 10(12):6-7. PubMed ID: 15645562
[No Abstract] [Full Text] [Related]
6. Conservative treatment vs. mastectomy without radiotherapy in aged women with breast cancer--a prospective and randomized trial.
Gori J; Castaño R; Engel H; Toziano M; Fischer C; Maletti G
Zentralbl Gynakol; 2000; 122(6):311-7. PubMed ID: 10904994
[TBL] [Abstract][Full Text] [Related]
7. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
[TBL] [Abstract][Full Text] [Related]
8. [Organ preserving treatment of breast cancer].
Topuzov EG; Krasnozhon DA
Vestn Khir Im I I Grek; 2004; 163(3):99-102. PubMed ID: 15317177
[No Abstract] [Full Text] [Related]
9. Arm edema after lumpectomy and breast irradiation.
Deutsch M; Flickinger JC
Am J Clin Oncol; 2003 Jun; 26(3):229-31. PubMed ID: 12796589
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
[TBL] [Abstract][Full Text] [Related]
11. [Current status and perspective in treatment of breast cancer in elderly women].
Zhang BN; Zhang HM
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):161-4. PubMed ID: 18756927
[No Abstract] [Full Text] [Related]
12. Radiotherapy and tamoxifen after mastectomy in postmenopausal women -- 20 year follow-up of the South Sweden Breast Cancer Group randomised trial SSBCG II:I.
Killander F; Anderson H; Rydén S; Möller T; Aspegren K; Ceberg J; Danewid C; Malmström P
Eur J Cancer; 2007 Sep; 43(14):2100-8. PubMed ID: 17644330
[TBL] [Abstract][Full Text] [Related]
13. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
Goss PE
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
[TBL] [Abstract][Full Text] [Related]
14. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.
Lash TL; Gurwitz JH; Silliman RA
J Am Geriatr Soc; 2005 Nov; 53(11):1889-96. PubMed ID: 16274369
[TBL] [Abstract][Full Text] [Related]
15. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
Koc M
J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
[No Abstract] [Full Text] [Related]
16. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
17. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
Sautter-Bihl ML
Strahlenther Onkol; 1999 Dec; 175(12):620-1. PubMed ID: 10633790
[No Abstract] [Full Text] [Related]
19. Recurrences and second primary breast cancers in older women with initial early-stage disease.
Geiger AM; Thwin SS; Lash TL; Buist DS; Prout MN; Wei F; Field TS; Ulcickas Yood M; Frost FJ; Enger SM; Silliman RA
Cancer; 2007 Mar; 109(5):966-74. PubMed ID: 17243096
[TBL] [Abstract][Full Text] [Related]
20. Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
Sanuki-Fujimoto N
Cancer Treat Rev; 2005 Oct; 31(6):496-500. PubMed ID: 16199127
[No Abstract] [Full Text] [Related]
[Next] [New Search]
